RAMAKRISHNA RAO: Open Payments
NPI 1457397903 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 28 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $370 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| Validus Pharmaceuticals LLC | 4 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Lundbeck LLC | 3 | $52 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Collegium Pharmaceutical, Inc. | 2 | $46 |
| ABBVIE INC. | 3 | $44 |
| Almatica Pharma LLC | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Noven Therapeutics, LLC | 1 | $22 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $22 |
Products named: CAPLYTA, REXULTI, Auvelity, Jornay PM, VRAYLAR, RALDESY, EQUETRO, LOREEV XR.
Industry payments across TX — which companies pay providers there.
